BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34622351)

  • 21. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.
    Ali MA; Li WF; Wang JH; Lin CC; Chen YJ; Lin TL; Lin TS; Lu SN; Wang CC; Chen CL
    HPB (Oxford); 2016 Oct; 18(10):851-860. PubMed ID: 27567971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
    Wu L; Hu A; Tam N; Zhang J; Lin M; Guo Z; He X
    PLoS One; 2012; 7(7):e41820. PubMed ID: 22848619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection.
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):93-7. PubMed ID: 25150375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
    Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
    World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Dig Dis Sci; 2018 Feb; 63(2):502-514. PubMed ID: 29238896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation.
    Ma KW; Chan ACY; She BWH; Chok KSH; Cheung TT; Dai JWC; Fung JYY; Lo CM
    Transplant Proc; 2018 May; 50(4):1087-1093. PubMed ID: 29731072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?
    Fang JZ; Xiang L; Hu YK; Yang Y; Zhu HD; Lu CD
    Clin Transplant; 2020 May; 34(5):e13831. PubMed ID: 32068916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma.
    Hirata Y; Kotera Y; Kato T; Ariizumi S; Kogiso T; Tokushige K; Honda G; Egawa H
    Transplant Proc; 2023 May; 55(4):901-905. PubMed ID: 37244836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
    Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
    Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis.
    Li HY; Wei YG; Yan LN; Li B
    World J Gastroenterol; 2012 May; 18(19):2415-22. PubMed ID: 22654435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience.
    Del Gaudio M; Ercolani G; Ravaioli M; Cescon M; Lauro A; Vivarelli M; Zanello M; Cucchetti A; Vetrone G; Tuci F; Ramacciato G; Grazi GL; Pinna AD
    Am J Transplant; 2008 Jun; 8(6):1177-85. PubMed ID: 18444925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection.
    Saito R; Amemiya H; Hosomura N; Kawaida H; Maruyama S; Shimizu H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2019 Jun; 39(6):3033-3038. PubMed ID: 31177145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.